Primary Site >> Colorectal Cancer
Gene >> KLK3
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Ref: Medically significant concentrations of prostate-specific antigen in serum assessed. PMID: 1690092 |
Ref: Immunocytochemical double staining of cytokeratin and prostate specific antigen in individual prostatic tumour cells. PMID: 7682210 Ref: Serum mucin antigens CASA and MSA in tumors of the breast, ovary, lung, pancreas, bladder, colon, and prostate. A blind trial with 420 patients. PMID: 7689923 Ref: Secondary mucinous adenocarcinoma of the prostate in a patient with ulcerative colitis. PMID: 8389496 |
Ref: Immunohistochemical identification of tumor markers in metastatic adenocarcinoma. A diagnostic adjunct in the determination of primary site. PMID: 8980361 Ref: [Prostate-specific antigen, acid phosphatases and rectal exploration in the diagnosis of prostatic cancer]. PMID: 9182382 Ref: Cytokeratins, CEA, and mucin histochemistry in the diagnosis and characterization of extramammary Paget's disease. PMID: 9208972 Ref: Raised prostate-specific antigen in adenocarcinoma of the colon. PMID: 9241551 Ref: Serum levels of endothelial and neural cell adhesion molecules in prostate cancer. PMID: 9254901 Ref: Early detection of prostate cancer. Serendipity strikes again. PMID: 9363972 Ref: Clinical experience with CD64-directed immunotherapy. An overview. PMID: 9435876 |
Ref: Low p27 expression predicts poor disease-free survival in patients with prostate cancer. PMID: 9474188 Ref: Combined analysis of studies of the effects of the matrix metalloproteinase inhibitor marimastat on serum tumor markers in advanced cancer: selection of a biologically active and tolerable dose for longer-term studies. PMID: 9607566 |
Ref: Induction of differentiation and apoptosis in the prostate cancer cell line LNCaP by sodium butyrate and galectin-1. PMID: 9917496 Ref: A nonsteroidal anti-inflammatory drug, flufenamic acid, inhibits the expression of the androgen receptor in LNCaP cells. PMID: 10537180 Ref: IGFs and human cancer: implications regarding the risk of growth hormone therapy. PMID: 10592443 |
Ref: Prostate-specific antigen: effect of pelvic irradiation. PMID: 10831696 Ref: Effects of ligand activation of peroxisome proliferator-activated receptor gamma in human prostate cancer. PMID: 10984506 Ref: Expression and characterization of trypsinogen produced in the human male genital tract. PMID: 11106574 Ref: Design of the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial. PMID: 11189684 |
Ref: Cancer screening for the primary care physician. PMID: 12243426 |
Ref: Measurement of serum total and free prostate-specific antigen in women with colorectal carcinoma. PMID: 11870506 Ref: Avoiding inappropriate surgery for secondary rectal cancer. PMID: 11944953 Ref: European best practice guidelines for renal transplantation. Section IV: Long-term management of the transplant recipient. IV.6.3. Cancer risk after renal transplantation. Solid organ cancers: prevention and treatment. PMID: 12091641 Ref: Secondary colonic adenocarcinoma of the prostate histologically mimicking prostatic ductal adenocarcinoma. PMID: 12400988 Ref: Radiation therapy after radical prostatectomy: strike early, strike hard! The case for adjuvant radiation therapy. PMID: 16985660 |
Ref: Transperineal prostate biopsy after abdominoperineal resection. PMID: 12478122 Ref: Screening men for prostate and colorectal cancer in the United States: does practice reflect the evidence? PMID: 12636464 Ref: Prostate-specific antigen-activated thapsigargin prodrug as targeted therapy for prostate cancer. PMID: 12837835 |
Ref: Mucinous urothelial-type adenocarcinoma of the prostate. PMID: 15204383 Ref: Testing for prostate and colorectal cancer: comparison of self-report and medical record audit. PMID: 15207983 Ref: Spread of prostate carcinoma to the perirectal lymph node basin: analysis of 112 rectal resections over a 10-year span for primary rectal adenocarcinoma. PMID: 15316314 Ref: The fibroblast growth factor receptor-4 Arg388 allele is associated with prostate cancer initiation and progression. PMID: 15448004 Ref: Age-related disparities in cancer screening: analysis of 2001 Behavioral Risk Factor Surveillance System data. PMID: 15506585 |
Ref: Behavioral associations between prostate and colon cancer screening. PMID: 15664097 Ref: [Ganglion curage in prostate cancer]. PMID: 16370170 Ref: [Future outlook for OTC examination (test)]. PMID: 16447686 Ref: Patients' anxiety and expectations: how they influence family physicians' decisions to order cancer screening tests. PMID: 16926946 |
Ref: Prostate-specific antigen-reactive cytotoxic T lymphocyte precursors in colon cancer patients. PMID: 16391848 Ref: Sister Mary Joseph's nodule as a presenting sign of internal malignancy. PMID: 16957443 |
Ref: Expression of CDX2 in benign tissue and adenocarcinoma of the prostate. PMID: 16949907 Ref: Morphological features of TMPRSS2-ERG gene fusion prostate cancer. PMID: 17385188 Ref: Delivery of cancer screening: how important is the preventive health examination? PMID: 17389289 Ref: Distinguishing prostatic from colorectal adenocarcinoma on biopsy samples: the role of morphology and immunohistochemistry. PMID: 17425391 Ref: Colorectal adenocarcinoma involving the prostate: report of 9 cases. PMID: 17868775 Ref: Value of tumor markers in diagnosing and monitoring colorectal cancer and strategies for further improvement: analysis of 130 cases. PMID: 17991322 Ref: Detection of prostate-specific antigen coupled to immunoglobulin M in prostate cancer patients. PMID: 18035503 Ref: Screening men for prostate cancer and colorectal cancer: is practice evidence-based? PMID: 18163923 |
Ref: Prostatic adenocarcinoma in colorectal biopsy: clinical and pathologic features. PMID: 18234278 Ref: Cancer-related knowledge, attitudes, and behaviors among Chamorros on Guam. PMID: 18359579 Ref: Effect of perioperative blood transfusion on prostate cancer recurrence. PMID: 18367097 Ref: Prohibitin identified by proteomic analysis of prostate biopsies distinguishes hyperplasia and cancer. PMID: 18384941 Ref: Influence of family history and preventive health behaviors on colorectal cancer screening in African Americans. PMID: 18543276 Ref: Promoting prostate-specific antigen informed decision-making. Evaluating two community-level interventions. PMID: 18617077 Ref: Radiation therapy for prostate cancer increases subsequent risk of bladder and rectal cancer: a population based cohort study. PMID: 18801517 Ref: Self-report versus medical records for assessing cancer-preventive services delivery. PMID: 18990740 Ref: National Academy of Clinical Biochemistry laboratory medicine practice guidelines for use of tumor markers in testicular, prostate, colorectal, breast, and ovarian cancers. PMID: 19042984 Ref: Sexual orientation and testing for prostate and colorectal cancers among men in California. PMID: 19300314 |
Ref: Body mass index and cancer screening in older American Indian and Alaska Native men. PMID: 19166569 Ref: Association of colorectal cancer and prostate cancer and impact of radiation therapy. PMID: 19531678 Ref: Are U.S. cancer screening test patterns consistent with guideline recommendations with respect to the age of screening initiation? PMID: 19821991 |
Ref: Evaluation of the ETS-related gene mRNA in urine for the detection of prostate cancer. PMID: 20160063 Ref: Differential CARM1 expression in prostate and colorectal cancers. PMID: 20462455 Ref: Data and trends in cancer screening in the United States: results from the 2005 National Health Interview Survey. PMID: 20597133 Ref: Serum levels of prostate specific antigen are elevated after colonoscopy. PMID: 21041992 Ref: Rectal metastasis of prostate cancer: about a case. PMID: 21629526 |
Ref: GAD1 is a biomarker for benign and malignant prostatic tissue. PMID: 21091088 Ref: An empirical evaluation of guidelines on prostate-specific antigen velocity in prostate cancer detection. PMID: 21350221 Ref: An analysis of world media reporting of two recent large randomized prospective trials investigating screening for prostate cancer. PMID: 21446935 Ref: Penile metastasis from adenocarcinoma of the prostate in a patient with colorectal carcinoma. PMID: 21489365 Ref: Colorectal, prostate, and skin cancer screening among Hispanic and White non-Hispanic men, 2000-2005. PMID: 21805813 Ref: Are United States and Canadian cancer screening rates consistent with guideline information regarding the age of screening initiation? PMID: 21890706 Ref: Furthering the prostate cancer screening debate (prostate cancer specific mortality and associated risks). PMID: 22154638 |
Ref: Transperineal prostate biopsy detects significant cancer in patients with elevated prostate-specific antigen (PSA) levels and previous negative transrectal biopsies. PMID: 22093091 Ref: Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in cancer progression and survival: a systematic review. PMID: 22116540 Ref: Incidence of cancer of unknown primary in Sweden: analysis by location of metastasis. PMID: 22387673 Ref: Current Challenges in Prostate Cancer Management and the Rationale behind Targeted Focal Therapy. PMID: 22649447 Ref: The role of the elastography in the diagnosis of prostate cancer: a retrospective study on 460 patients. PMID: 23210408 |
Ref: High-dose-rate brachytherapy for prostate cancer in a previously radiated patient with polyethylene glycol hydrogel spacing to reduce rectal dose: case report and review of the literature. PMID: 22543116 Ref: Tumor markers in clinical practice: a review focusing on common solid cancers. PMID: 22584792 Ref: Transient therapy-related surge in serum tumor biomarkers: characterizing behavior and postulating its biologic role. PMID: 23040007 Ref: HOXB13 G84E mutation in Finland: population-based analysis of prostate, breast, and colorectal cancer risk. PMID: 23292082 Ref: A cluster-randomised, parallel group, controlled intervention study of genetic prostate cancer risk assessment and use of PSA tests in general practice--the ProCaRis study: study protocol. PMID: 23457331 Ref: Clinical significance of kallikrein-related peptidase (KLK10) mRNA expression in colorectal cancer. PMID: 23499583 Ref: The role of cryosurgery of the prostate for nonsurgical candidates. PMID: 24018080 Ref: Should all colorectal cancer patients over age 60 be screened for prostate cancer? PMID: 24367864 |
Ref: Do racial disparities exist in the use of prostate cancer screening and detection tools in veterans? PMID: 23506962 Ref: Electronic health record-based triggers to detect potential delays in cancer diagnosis. PMID: 23873756 Ref: [Three-year follow-up of 12 patients with prostate cancer treated with monthly degarelix in a phase II clinical trial]. PMID: 24423954 Ref: Mutation status of somatic EGFR and KRAS genes in Chinese patients with prostate cancer (PCa). PMID: 24595526 Ref: Serum omentin level in patients with prostate cancer. PMID: 24659266 Ref: Expression of RABEX-5 and its clinical significance in prostate cancer. PMID: 24716822 Ref: Have screening harms become newsworthy? News coverage of prostate and colorectal cancer screening since the 2008 USPSTF recommendation changes. PMID: 24859436 Ref: Predictions for the future of kallikrein-related peptidases in molecular diagnostics. PMID: 24927162 Ref: If you have an active vagus nerve, cancer stage may no longer be important. PMID: 25001652 Ref: Examining connections between screening for breast, cervical and prostate cancer and colorectal cancer screening. PMID: 25143785 |
Ref: Use of a web-based survey to facilitate shared decision making for patients eligible for cancer screening. PMID: 25047659 Ref: Patterns of changing cancer risks with time since diagnosis of a sibling. PMID: 25267314 Ref: Assessing the appropriateness of outpatient abdominopelvic CT and MRI examinations using the American College of Radiology Appropriateness Criteria. PMID: 25442803 Ref: Prognostic impact of synchronous second primary malignancies on the overall survival of patients with metastatic prostate cancer. PMID: 25444987 Ref: Surveillance of the adult cancer survivor. PMID: 25591198 Ref: Does screening for disease save lives in asymptomatic adults? Systematic review of meta-analyses and randomized trials. PMID: 25596211 Ref: Isoxanthohumol--Biologically active hop flavonoid. PMID: 25771121 Ref: Effect of the USPSTF Grade D Recommendation against Screening for Prostate Cancer on Incident Prostate Cancer Diagnoses in the United States. PMID: 26087383 |
Ref: HOXB13 as an immunohistochemical marker of prostatic origin in metastatic tumors. PMID: 26590121 Ref: Comparative study of tumor markers in patients with colorectal carcinoma before and after chemotherapy. PMID: 27004218 Ref: Disparities in disease presentation in the four screenable cancers according to health insurance status. PMID: 27091437 |
Ref: Free/Total Serum Prostate-Specific Antigen Ratio in Women with Colorectal Cancer Has Prognostic Significance. PMID: 27447478 Ref: Lesion Targeted CT-Guided Transgluteal Prostate Biopsy in Combination With Prebiopsy MRI in Patients Without Rectal Access. PMID: 27800298 Ref: Prostate and Colorectal Cancer Screening Uptake among US and Foreign-Born Males: Evidence from the 2015 NHIS Survey. PMID: 27838809 Ref: Clinicopathological study of 9 cases of prostate cancer involving the rectal wall. PMID: 28095874 Ref: TRUS Biopsy Yield in Indian Population: A Retrospective Analysis. PMID: 28384926 Ref: EMT circulating tumor cells detected by cell-surface vimentin are associated with prostate cancer progression. PMID: 28521303 |
Ref: Health Screening PMID: 28613785 Ref: Prostate-specific antigen (PSA) as a possible biomarker in non-prostatic cancer: A review. PMID: 29579692 Ref: Phenylbutyl isoselenocyanate induces reactive oxygen species to inhibit androgen receptor and to initiate p53-mediated apoptosis in LNCaP prostate cancer cells. PMID: 29668110 Ref: Implications of false-positive results for future cancer screenings. PMID: 29682740 Ref: Clean Colorectum at Diagnostic Colonoscopy: Subsequent Detection of Extracolonic Malignancies by Plasma Protein Biomarkers? PMID: 29872358 Ref: Screening key long non-coding RNAs in early-stage colon adenocarcinoma by RNA-sequencing. PMID: 30182733 Ref: [A Case of Rectum-Infiltrating Prostate Cancer Mimicking Prostate-Infiltrating Rectal Cancer]. PMID: 30369229 Ref: Distinct Imaging Characteristics of Different Metastases From Primary Prostate Adenocarcinoma and Rectal Carcinoid Tumor on 18F-Fluciclovine and 68Ga-DOTATATE PET/CT. PMID: 30371597 |